Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Samalizumab |
| Trade Name | |
| Synonyms | ALXN6000 |
| Drug Descriptions |
Samalizumab (ALXN6000) is a humanized antibody against CD200 which blocks CD200-CD200R interaction, resulting in enhanced immune response (Blood 2010 116:2465, PMID: 31443741). |
| DrugClasses | |
| CAS Registry Number | 1073059-33-2 |
| NCIT ID | C77891 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cytarabine + Daunorubicin + Samalizumab | Cytarabine Daunorubicin Samalizumab | 0 | 1 |
| Samalizumab | Samalizumab | 0 | 1 |